O impacto de serviços farmacêuticos na cessação do tabagismo: uma revisão integrativa
DOI:
https://doi.org/10.22481/rsc.v19i2.11739Palabras clave:
Abandono do Uso de Tabaco, Assistência farmacêutica, Promoção da saúde, Terapia comportamentalResumen
Smoking is a risk factor for the development of several diseases and the biggest preventable cause of illness and early death in the world. In this way, it’s less expensive to stop smoking than to treat the diseases caused by it, and pharmaceutical services can help. The objective of this review was to gather studies that described the pharmaceutical services provided for smoking cessation, as well as the clinical impacts arising from it. For this, an integrative literature review was carried out in Pubmed and Lilacs databases, using descriptors referring to smoking cessation and pharmaceutical services. Among the 342 articles retrieved, 21 were selected for this study. Three types of pharmaceutical services were identified: health condition management (n=7), health education (n=13) and pharmacotherapy follow-up (n=1). Most of the services were offered in the community pharmacy and involved a behavioral and brief intervention. Group interventions were more effective than individual interventions. All studies evaluated smoking cessation through the patient's report and only one of them evaluated the impact on quality of life, which was positive. Pharmacotherapy for smoking cessation provided in the services (nicotine replacement therapy, bupropion and varenicline) were consistent with the literature, with nicotine replacement therapy being prescribed by the pharmacist in one of the services. Evidence demonstrates that pharmaceutical services for smoking cessation have great potential for health promotion. Therefore, public policies that promote pharmacists’ training to provide activities aimed at smoking cessation in health services should be considered by managers.
Descargas
Citas
World Health Organization (WHO). Tobacco. [internet] 2020 [acesso em 2021 Jan 20]. Disponível em: https://www.who.int/news-room/fact-sheets/detail/tobacco.
World Health Organization (WHO). The Top 10 Causes of Death [internet] 2020 [acesso em 2021 Fev 19]. Disponível em: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death.
Ministério da Saúde (Brasil). Instituto Nacional de Câncer (INCA). Tabagismo [internet] 2020 [acesso em 2021 Jan 20]. Disponível em: https://www.inca.gov.br/tabagismo.
Ministério da Saúde (Brasil). Política Nacional de Promoção da Saúde. Brasília, 2006 [acesso em 2021 Jul 07]. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/politica_nacional_promocao_saude_3ed.pdf.
Ministério da Saúde (Brasil). Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Cadernos de Atenção Básica. n.40 [internet]. Brasília, 2015. 156 p [acesso em 2021 Jan 20]. Disponível em: http://189.28.128.100/dab/docs/portaldab/publicacoes/caderno_40.pdf.
Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based outpatient clinic. J Am Pharm Assoc (2003). 2004 Nov-Dec;44(6):700-14; quiz 714-5. doi: 10.1331/1544345042467290. PMID: 15637853.
Conselho Federal de Farmácia. Centro Brasileiro de Informação sobre Medicamentos (CEBRIM/CFF). O Papel do Farmacêutico Comunitário na Cessação do Tabagismo [internet]. Ano XII, n. 3, mai-ago 2007 [acesso em 2021 Jan 20]. ISSN 1413-9626. Disponível em: https://www.cff.org.br/sistemas/geral/revista/pdf/8/095a098farmacoterapeutica.pdf.
Condinho M, Fernández-Llimos F, Figueiredo IV, Sinogas C. Smoking cessation in a community pharmacy: preliminary results of a pharmaceutical care programme. Vitae [Internet]. 2015 Apr [acesso em 2021 Ago 15]; 22(1): 42-46. https://doi.org/10.17533/udea.vitae.v22n1a05.
Shen X, Bachyrycz A, Anderson JR, Tinker D, Raisch DW. Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico. J Manag Care Spec Pharm. 2014 Jun;20(6):579-87. doi: 10.18553/jmcp.2014.20.6.579. PMID: 24856596.
Khan N, Anderson JR, Du J, Tinker D, Bachyrycz AM, Namdar R. Smoking cessation and its predictors: results from a community-based pharmacy tobacco cessation program in New Mexico. Ann Pharmacother. 2012 Sep;46(9):1198-204. doi: 10.1345/aph.1P146. Epub 2012 Aug 21. PMID: 22911338.
Gong J, Baker CL, Zou KH, Bruno M, Jumadilova Z, Lawrence D, Wilson B, Ewel C. A Pragmatic Randomized Trial Comparing Telephone-Based Enhanced Pharmacy Care and Usual Care to Support Smoking Cessation. J Manag Care Spec Pharm. 2016 Dec;22(12):1417-1425. doi: 10.18553/jmcp.2016.22.12.1417. PMID: 27882838.
Barbero González JA, Quintas Rodríguez AM, Camacho JE. Deshabituación tabáquica desde la farmacia comunitaria [Smoking cessation from the community pharmacy]. Aten Primaria. 2000 Dec;26(10):693-6. Spanish. doi: 10.1016/s0212-6567(00)78754-3. PMID: 11200515; PMCID: PMC7681404.
Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):51-6. doi: 10.1331/108658002763538071. PMID: 11833517.
Watanabe F, Shinohara K, Dobashi A, Amagai K, Hara K, Kurata K, Iizima H, Shimakawa K, Shimada M, Abe S, Takei K, Kamei M. Assessment of Assistance in Smoking Cessation Therapy by Pharmacies in Collaboration with Medical Institutions- Implementation of a Collaborative Drug Therapy Management Protocol Based on a Written Agreement between Physicians and Pharmacists. Yakugaku Zasshi. 2016;136(9):1243-54. doi: 10.1248/yakushi.16-00013. PMID: 27592827.
Farley A, Tearne S, Taskila T, Williams RH, MacAskill S, Etter JF, Aveyard P. A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists - The RedPharm study. BMC Public Health. 2017 Feb 17;17(1):210. doi: 10.1186/s12889-017-4116-z.
Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001 Feb;96(2):325-31. doi: 10.1046/j.1360-0443.2001.96232516.x. PMID: 11182878.
Ragucci KR, Shrader SP. A method for educating patients and documenting smoking status in an electronic medical record. Ann Pharmacother. 2009 Oct;43(10):1616-20. doi: 10.1345/aph.1M301. Epub 2009 Sep 8. PMID: 19737992.
Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009 Feb;43(2):194-201. doi: 10.1345/aph.1L556. Epub 2009 Feb 3. PMID: 19193572.
Philbrick Ann M., Newkirk Erin N., B. Farris Karen, L. McDanel Deanna, E. Horner Kathleen. Effect of a pharmacist managed smoking cessation clinic on quit rates. Pharmacy Pract (Granada) [Internet]. 2009 Sep [acesso em 2021 Ago 15]; 7( 3 ): 150-156. ISSN 1886-3655.
Bauld L, Chesterman J, Ferguson J, Judge K. A comparison of the effectiveness of group-based and pharmacy-led smoking cessation treatment in Glasgow. Addiction. 2009 Feb;104(2):308-16. doi: 10.1111/j.1360-0443.2008.02446.x. PMID: 19149828.
Augustine JM, Taylor AM, Pelger M, Schiefer D, Warholak TL. Smoking quit rates among patients receiving pharmacist-provided pharmacotherapy and telephonic smoking cessation counseling. J Am Pharm Assoc (2003). 2016 Mar-Apr;56(2):129-36. doi: 10.1016/j.japh.2016.02.001. PMID: 27000162.
Costello MJ, Sproule B, Victor JC, Leatherdale ST, Zawertailo L, Selby P. Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers. Cancer Causes Control. 2011 Feb;22(2):167-80. doi: 10.1007/s10552-010-9672-9. Epub 2010 Dec 12. PMID: 21153694.
Roth MT, Westman EC. Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. Pharmacotherapy. 2001 May;21(5):636-41. doi: 10.1592/phco.21.6.636.34548. PMID: 11349752.
Roth MT, Andrus MR, Westman EC. Outcomes from an outpatient smoking-cessation clinic. Pharmacotherapy. 2005 Feb;25(2):279-88. doi: 10.1592/phco.25.2.279.56957. PMID: 15767242.
Smith MD, McGhan WF, Lauger G. Pharmacist counseling and outcomes of smoking cessation. Am Pharm. 1995 Aug;NS35(8):20-9; 32. doi: 10.1016/s0160-3450(15)30095-7. PMID: 7677052.
Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002 Jun;22(6):759-65. doi: 10.1592/phco.22.9.759.34073. PMID: 12066966.
Hajek P. Withdrawal-oriented therapy for smokers. Br J Addict. 1989 Jun;84(6):591-8. doi: 10.1111/j.1360-0443.1989.tb03474.x. PMID: 2752191.
Litke J, Spoutz L, Ahlstrom D, Perdew C, Llamas W, Erickson K. Impact of the clinical pharmacy specialist in telehealth primary care. Am J Health Syst Pharm. 2018 Jul 1;75(13):982-986. doi: 10.2146/ajhp170633. PMID: 29941537.
Ministério da Saúde (Brasil). Instituto Nacional de Câncer (INCA). O que é a Convenção-Quadro para o Controle do Tabaco [internet]. 2020 [acesso em 2021 Jul 07]. Disponível em: https://www.inca.gov.br/en/node/1378.
Tolotti, MD, Davoglio, TR. Evolução Histórica da Propaganda, Legislação Antitabagismo e Consumo de Cigarro no Brasil. Revista de Psicologia da IMED [Internet].2010 2(2): 420-432. doi:https://doi.org/10.18256/2175-5027/psico-imed.v2n2p420-432
Fiore, MC et al. Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline. Rockville, MD: USPHS, U.S. Department of Health and Human Services, 2008.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Revista Saúde.com
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.